Skip to main content
NCBI home page
Gut logoLink to Gut
. 1997 Jan;40(1):1–4. doi: 10.1136/gut.40.1.1

Role of cytokines and their inhibitors in acute pancreatitis.

A Kingsnorth 1
PMCID: PMC1026998  PMID: 9155566

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ais G., López-Farre A., Gomez-Garre D. N., Novo C., Romeo J. M., Braquet P., López-Novoa J. M. Role of platelet-activating factor in hemodynamic derangements in an acute rodent pancreatic model. Gastroenterology. 1992 Jan;102(1):181–187. doi: 10.1016/0016-5085(92)91799-a. [DOI] [PubMed] [Google Scholar]
  2. Arend W. P. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J Clin Invest. 1991 Nov;88(5):1445–1451. doi: 10.1172/JCI115453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Banerjee A. K., Galloway S. W., Kingsnorth A. N. Experimental models of acute pancreatitis. Br J Surg. 1994 Aug;81(8):1096–1103. doi: 10.1002/bjs.1800810805. [DOI] [PubMed] [Google Scholar]
  4. Beger H. G., Bittner R., Block S., Büchler M. Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology. 1986 Aug;91(2):433–438. doi: 10.1016/0016-5085(86)90579-2. [DOI] [PubMed] [Google Scholar]
  5. Corfield A. P., Cooper M. J., Williamson R. C. Acute pancreatitis: a lethal disease of increasing incidence. Gut. 1985 Jul;26(7):724–729. doi: 10.1136/gut.26.7.724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Curley P. J., McMahon M. J., Lancaster F., Banks R. E., Barclay G. R., Shefta J., Boylston A. W., Whicher J. T. Reduction in circulating levels of CD4-positive lymphocytes in acute pancreatitis: relationship to endotoxin, interleukin 6 and disease severity. Br J Surg. 1993 Oct;80(10):1312–1315. doi: 10.1002/bjs.1800801031. [DOI] [PubMed] [Google Scholar]
  7. Dabrowski A., Gabryelewicz A., Chyczewski L. The effect of platelet activating factor antagonist (BN 52021) on acute experimental pancreatitis with reference to multiorgan oxidative stress. Int J Pancreatol. 1995 Apr;17(2):173–180. doi: 10.1007/BF02788536. [DOI] [PubMed] [Google Scholar]
  8. Deitch E. A. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg. 1992 Aug;216(2):117–134. doi: 10.1097/00000658-199208000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Emanuelli G., Montrucchio G., Dughera L., Gaia E., Lupia E., Battaglia E., De Martino A., De Giuli P., Gubetta L., Camussi G. Role of platelet activating factor in acute pancreatitis induced by lipopolysaccharides in rabbits. Eur J Pharmacol. 1994 Aug 22;261(3):265–272. doi: 10.1016/0014-2999(94)90116-3. [DOI] [PubMed] [Google Scholar]
  10. Emanuelli G., Montrucchio G., Gaia E., Dughera L., Corvetti G., Gubetta L. Experimental acute pancreatitis induced by platelet activating factor in rabbits. Am J Pathol. 1989 Feb;134(2):315–326. [PMC free article] [PubMed] [Google Scholar]
  11. Emanuelli G., Montrucchio G., Gaia E., Dughera L., Corvetti G., Gubetta L. Experimental acute pancreatitis induced by platelet activating factor in rabbits. Am J Pathol. 1989 Feb;134(2):315–326. [PMC free article] [PubMed] [Google Scholar]
  12. Exley A. R., Leese T., Holliday M. P., Swann R. A., Cohen J. Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut. 1992 Aug;33(8):1126–1128. doi: 10.1136/gut.33.8.1126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Feldmann M. Cytokine networks: do we understand them well enough to facilitate clinical benefits? Eur Cytokine Netw. 1991 Jan-Feb;2(1):5–9. [PubMed] [Google Scholar]
  14. Fernández-del Castillo C., Rattner D. W., Warshaw A. L. Acute pancreatitis. Lancet. 1993 Aug 21;342(8869):475–479. doi: 10.1016/0140-6736(93)91598-g. [DOI] [PubMed] [Google Scholar]
  15. Formela L. J., Galloway S. W., Kingsnorth A. N. Inflammatory mediators in acute pancreatitis. Br J Surg. 1995 Jan;82(1):6–13. doi: 10.1002/bjs.1800820105. [DOI] [PubMed] [Google Scholar]
  16. Formela L. J., Wood L. M., Whittaker M., Kingsnorth A. N. Amelioration of experimental acute pancreatitis with a potent platelet-activating factor antagonist. Br J Surg. 1994 Dec;81(12):1783–1785. doi: 10.1002/bjs.1800811224. [DOI] [PubMed] [Google Scholar]
  17. Fujimura K., Kubota Y., Ogura M., Yamaguchi T., Binnaka T., Tani K., Kitagawa S., Mizuno T., Inoue K. Role of endogenous platelet-activating factor in caerulein-induced acute pancreatitis in rats: protective effects of a PAF-antagonist. J Gastroenterol Hepatol. 1992 Mar-Apr;7(2):199–202. doi: 10.1111/j.1440-1746.1992.tb00962.x. [DOI] [PubMed] [Google Scholar]
  18. Gosling P., Shearman C. P. Can we predict disease severity in acute pancreatitis? Ann Clin Biochem. 1992 Jan;29(Pt 1):9–10. doi: 10.1177/000456329202900102. [DOI] [PubMed] [Google Scholar]
  19. Grewal H. P., Kotb M., el Din A. M., Ohman M., Salem A., Gaber L., Gaber A. O. Induction of tumor necrosis factor in severe acute pancreatitis and its subsequent reduction after hepatic passage. Surgery. 1994 Feb;115(2):213–221. [PubMed] [Google Scholar]
  20. Gross V., Andreesen R., Leser H. G., Ceska M., Liehl E., Lausen M., Farthmann E. H., Schölmerich J. Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest. 1992 Mar;22(3):200–203. doi: 10.1111/j.1365-2362.1992.tb01826.x. [DOI] [PubMed] [Google Scholar]
  21. Guice K. S., Oldham K. T., Remick D. G., Kunkel S. L., Ward P. A. Anti-tumor necrosis factor antibody augments edema formation in caerulein-induced acute pancreatitis. J Surg Res. 1991 Dec;51(6):495–499. doi: 10.1016/0022-4804(91)90171-h. [DOI] [PubMed] [Google Scholar]
  22. Heath D. I., Cruickshank A., Gudgeon M., Jehanli A., Shenkin A., Imrie C. W. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut. 1993 Jan;34(1):41–45. doi: 10.1136/gut.34.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Heuer H. O. Current status of PAF antagonists. Clin Exp Allergy. 1992 Nov;22(11):980–983. doi: 10.1111/j.1365-2222.1992.tb03024.x. [DOI] [PubMed] [Google Scholar]
  24. Imaizumi T. A., Stafforini D. M., Yamada Y., McIntyre T. M., Prescott S. M., Zimmerman G. A. Platelet-activating factor: a mediator for clinicians. J Intern Med. 1995 Jul;238(1):5–20. doi: 10.1111/j.1365-2796.1995.tb00894.x. [DOI] [PubMed] [Google Scholar]
  25. Jaakkola M., Nordback I. Pancreatitis in Finland between 1970 and 1989. Gut. 1993 Sep;34(9):1255–1260. doi: 10.1136/gut.34.9.1255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Jancar S., Abdo E. E., Sampietre S. N., Kwasniewski F. H., Coelho A. M., Bonizzia A., Machado M. C. Effect of PAF antagonists on cerulein-induced pancreatitis. J Lipid Mediat Cell Signal. 1995 Jan;11(1):41–49. doi: 10.1016/0929-7855(94)00026-9. [DOI] [PubMed] [Google Scholar]
  27. Kald B., Kald A., Ihse I., Tagesson C. Release of platelet-activating factor in acute experimental pancreatitis. Pancreas. 1993 Jul;8(4):440–442. doi: 10.1097/00006676-199307000-00006. [DOI] [PubMed] [Google Scholar]
  28. Kingsnorth A. N., Galloway S. W., Formela L. J. Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis. Br J Surg. 1995 Oct;82(10):1414–1420. doi: 10.1002/bjs.1800821039. [DOI] [PubMed] [Google Scholar]
  29. Koltai M., Guinot P., Hosford D., Braquet P. G. Platelet-activating factor antagonists: scientific background and possible clinical applications. Adv Pharmacol. 1994;28:81–167. [PubMed] [Google Scholar]
  30. Konturek S. J., Dembinski A., Konturek P. J., Warzecha Z., Jaworek J., Gustaw P., Tomaszewska R., Stachura J. Role of platelet activating factor in pathogenesis of acute pancreatitis in rats. Gut. 1992 Sep;33(9):1268–1274. doi: 10.1136/gut.33.9.1268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Leach S. D., Gorelick F. S., Modlin I. M. Acute pancreatitis at its centenary. The contribution of Reginald Fitz. Ann Surg. 1990 Jul;212(1):109–113. doi: 10.1097/00000658-199007000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Leonhardt U., Fayyazzi A., Seidensticker F., Stöckmann F., Söling H. D., Creutzfeldt W. Influence of a platelet-activating factor antagonist on severe pancreatitis in two experimental models. Int J Pancreatol. 1992 Oct;12(2):161–166. doi: 10.1007/BF02924640. [DOI] [PubMed] [Google Scholar]
  33. Mann D. V., Hershman M. J., Hittinger R., Glazer G. Multicentre audit of death from acute pancreatitis. Br J Surg. 1994 Jun;81(6):890–893. doi: 10.1002/bjs.1800810632. [DOI] [PubMed] [Google Scholar]
  34. Messori A., Rampazzo R., Scroccaro G., Olivato R., Bassi C., Falconi M., Pederzoli P., Martini N. Effectiveness of gabexate mesilate in acute pancreatitis. A metaanalysis. Dig Dis Sci. 1995 Apr;40(4):734–738. doi: 10.1007/BF02064970. [DOI] [PubMed] [Google Scholar]
  35. Nevalainen T. J., Grönroos J. M., Kortesuo P. T. Pancreatic and synovial type phospholipases A2 in serum samples from patients with severe acute pancreatitis. Gut. 1993 Aug;34(8):1133–1136. doi: 10.1136/gut.34.8.1133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Nevalainen T. J. Phospholipase A2 in acute pancreatitis. Scand J Gastroenterol. 1988 Oct;23(8):897–904. doi: 10.3109/00365528809090144. [DOI] [PubMed] [Google Scholar]
  37. Norman J. G., Franz M. G., Fink G. S., Messina J., Fabri P. J., Gower W. R., Carey L. C. Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann Surg. 1995 Jun;221(6):625–634. doi: 10.1097/00000658-199506000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Norman J., Franz M., Messina J., Riker A., Fabri P. J., Rosemurgy A. S., Gower W. R., Jr Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery. 1995 Jun;117(6):648–655. doi: 10.1016/s0039-6060(95)80008-5. [DOI] [PubMed] [Google Scholar]
  39. O'Nualláin E. M., Puri P., Mealy K., Reen D. J. Induction of interleukin-1 receptor antagonist (IL-1ra) following surgery is associated with major trauma. Clin Immunol Immunopathol. 1995 Jul;76(1 Pt 1):96–101. doi: 10.1006/clin.1995.1093. [DOI] [PubMed] [Google Scholar]
  40. Paajanen H., Laato M., Jaakkola M., Pulkki K., Niinikoski J., Nordback I. Serum tumour necrosis factor compared with C-reactive protein in the early assessment of severity of acute pancreatitis. Br J Surg. 1995 Feb;82(2):271–273. doi: 10.1002/bjs.1800820244. [DOI] [PubMed] [Google Scholar]
  41. Paran H., Neufeld D., Mayo A., Shwartz I., Singer P., Kaplan O., Skornik Y., Klausner J., Freund U. Preliminary report of a prospective randomized study of octreotide in the treatment of severe acute pancreatitis. J Am Coll Surg. 1995 Aug;181(2):121–124. [PubMed] [Google Scholar]
  42. Pederzoli P., Bassi C., Vesentini S., Campedelli A. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet. 1993 May;176(5):480–483. [PubMed] [Google Scholar]
  43. Platanias L. C., Vogelzang N. J. Interleukin-1: biology, pathophysiology, and clinical prospects. Am J Med. 1990 Nov;89(5):621–629. doi: 10.1016/0002-9343(90)90181-c. [DOI] [PubMed] [Google Scholar]
  44. Rinderknecht H. Fatal pancreatitis, a consequence of excessive leukocyte stimulation? Int J Pancreatol. 1988 Mar;3(2-3):105–112. doi: 10.1007/BF02798921. [DOI] [PubMed] [Google Scholar]
  45. Runkel N. S., Moody F. G., Smith G. S., Rodriguez L. F., LaRocco M. T., Miller T. A. The role of the gut in the development of sepsis in acute pancreatitis. J Surg Res. 1991 Jul;51(1):18–23. doi: 10.1016/0022-4804(91)90064-s. [DOI] [PubMed] [Google Scholar]
  46. Sainio V., Kemppainen E., Puolakkainen P., Taavitsainen M., Kivisaari L., Valtonen V., Haapiainen R., Schröder T., Kivilaakso E. Early antibiotic treatment in acute necrotising pancreatitis. Lancet. 1995 Sep 9;346(8976):663–667. doi: 10.1016/s0140-6736(95)92280-6. [DOI] [PubMed] [Google Scholar]
  47. Snyder F. Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes. Biochim Biophys Acta. 1995 Feb 9;1254(3):231–249. doi: 10.1016/0005-2760(94)00192-2. [DOI] [PubMed] [Google Scholar]
  48. Steer M. L., Meldolesi J. The cell biology of experimental pancreatitis. N Engl J Med. 1987 Jan 15;316(3):144–150. doi: 10.1056/NEJM198701153160306. [DOI] [PubMed] [Google Scholar]
  49. Summers J. B., Albert D. H. Platelet activating factor antagonists. Adv Pharmacol. 1995;32:67–168. doi: 10.1016/s1054-3589(08)61012-1. [DOI] [PubMed] [Google Scholar]
  50. Tanaka N., Murata A., Uda K., Toda H., Kato T., Hayashida H., Matsuura N., Mori T. Interleukin-1 receptor antagonist modifies the changes in vital organs induced by acute necrotizing pancreatitis in a rat experimental model. Crit Care Med. 1995 May;23(5):901–908. doi: 10.1097/00003246-199505000-00019. [DOI] [PubMed] [Google Scholar]
  51. Tomaszewska R., Dembiński A., Warzecha Z., Banaś M., Konturek S. J., Stachura J. Platelet activating factor (PAF) inhibitor (TCV-309) reduces caerulein- and PAF-induced pancreatitis. A morphologic and functional study in the rat. J Physiol Pharmacol. 1992 Dec;43(4):345–352. [PubMed] [Google Scholar]
  52. Uden S., Bilton D., Nathan L., Hunt L. P., Main C., Braganza J. M. Antioxidant therapy for recurrent pancreatitis: placebo-controlled trial. Aliment Pharmacol Ther. 1990 Aug;4(4):357–371. doi: 10.1111/j.1365-2036.1990.tb00482.x. [DOI] [PubMed] [Google Scholar]
  53. Van Laethem J. L., Marchant A., Delvaux A., Goldman M., Robberecht P., Velu T., Devière J. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology. 1995 Jun;108(6):1917–1922. doi: 10.1016/0016-5085(95)90158-2. [DOI] [PubMed] [Google Scholar]
  54. Vargaftig B. B. Paf. A mediator in search of a disease. Clin Rev Allergy. 1994 Winter;12(4):419–421. [PubMed] [Google Scholar]
  55. Venable M. E., Zimmerman G. A., McIntyre T. M., Prescott S. M. Platelet-activating factor: a phospholipid autacoid with diverse actions. J Lipid Res. 1993 May;34(5):691–702. [PubMed] [Google Scholar]
  56. Warshaw A. L. Damage prevention versus damage control in acute pancreatitis. Gastroenterology. 1993 Apr;104(4):1216–1219. doi: 10.1016/0016-5085(93)90299-r. [DOI] [PubMed] [Google Scholar]
  57. Windsor J. A., Fearon K. C., Ross J. A., Barclay G. R., Smyth E., Poxton I., Garden O. J., Carter D. C. Role of serum endotoxin and antiendotoxin core antibody levels in predicting the development of multiple organ failure in acute pancreatitis. Br J Surg. 1993 Aug;80(8):1042–1046. doi: 10.1002/bjs.1800800840. [DOI] [PubMed] [Google Scholar]
  58. Yotsumoto F., Manabe T., Kyogoku T., Hirano T., Ohshio G., Yamamoto M., Imamura T., Yoshitomi S. Platelet-activating factor involvement in the aggravation of acute pancreatitis in rabbits. Digestion. 1994;55(4):260–267. doi: 10.1159/000201158. [DOI] [PubMed] [Google Scholar]
  59. Zhou W., McCollum M. O., Levine B. A., Olson M. S. Role of platelet-activating factor in pancreatitis-associated acute lung injury in the rat. Am J Pathol. 1992 Apr;140(4):971–979. [PMC free article] [PubMed] [Google Scholar]
  60. de Beaux A. C., Goldie A. S., Ross J. A., Carter D. C., Fearon K. C. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg. 1996 Mar;83(3):349–353. doi: 10.1002/bjs.1800830317. [DOI] [PubMed] [Google Scholar]
  61. de Beaux A. C., Palmer K. R., Carter D. C. Factors influencing morbidity and mortality in acute pancreatitis; an analysis of 279 cases. Gut. 1995 Jul;37(1):121–126. doi: 10.1136/gut.37.1.121. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES